ArticleInternational journal of legal medicine2022
GITAD 2020: quality assurance test through 20 years of experience.
Article in International journal of legal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
GITAD (Grupo Iberoamericano de Trabajo en Análisis de DNA) was founded in 1998 as the first operational group of AICEF (Academia Iberoamericana de Criminalística y Estudios Forenses), formally created in 1999. The mission and the vision of GITAD are to promote the development of forensic genetics in Ibero-American countries and to achieve the maximum level of innovation and quality in each country, and with that aim, a proficiency test was developed. Since 1999, the member laboratories receive four reference samples with the objective of obtaining the genetic profile with their routine protocols, a theoretical exercise since 2003, and since 2007, it was incorporated a forensic sample, which changes every year. The consensus results and the different discrepancies are discussed in an annual meeting. This article illustrates the evolution of the proficiency test through 20 years from different points of view: the increase of participant laboratories, the evolution of the different DNA typing techniques reported by the Ibero-American participant laboratories, the challenges that the proficiency test have met, and future perspectives for a continuous improvement of the proficiency test, especially regarding its accreditation under ISO 17043.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.